Director / Editor: Victor Teboul, Ph.D.

Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Pricey Hepatitis C Drug Draws Criticism

To hear scientists talk about it, it’s nothing short of a wonder drug. The drug is sofosbuvir, called Solvadi by its manufacturer, and its effectiveness in treating hepatitis C is so pronounced that the U.S. regulators designated it “breakthrough therapy” when they approved it for U.S. markets last year. The catch is that it doesn’t come cheap: a single pill costs $1,000, meaning the 12-week daily dose prescribed for most patients will cost $84,000. That has brought howls of protests...

Read complete article

~	Our research shows what the rental market is really like for international students

~	Is it time for Australia to reassess its position on France’s role in New Caledonia?

~	Iraq: Repeal Anti-LGBT Law

~	The ‘dead internet theory’ makes eerie claims about an AI-run web. The truth is more sinister

~	Iran crash: President Raisi’s fate raises concerns in Tehran over potential loss of loyalist

~	Some sports leaders are trying to defy term limits – which can open the door to corruption

~	South Korea: Extend Health Benefits to Same-Sex Partners

~	Fast-track laws, parliamentary urgency, Treaty tension, media retreat: warning signs for NZ’s ‘brittle’ democracy

~	Labor and Albanese gain in post-budget Newspoll, but other polls don’t look as rosy

~	I can’t afford olive oil. What else can I use?